Division of Hematology and Oncology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan ; Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Department of General Surgery, Chi Mei Medical Center, Tainan 710, Taiwan.
Evid Based Complement Alternat Med. 2013;2013:121725. doi: 10.1155/2013/121725. Epub 2013 Dec 22.
Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related death worldwide. Due to the difficulties of early diagnosis, curative treatments are not available for most patients. Palliative treatments such as chemotherapy are often associated with low response rate, strong adverse effects and limited clinical benefits for patients. The alternative approaches such as fermented wheat germ extract (FWGE) with anti-tumor efficacy may provide improvements in the clinical outcome of current therapy for HCC. This study aimed to clarify antitumor efficacy of FWGE and the combination drug effect of FWGE with chemotherapeutic agents, cisplatin and 5-fluorouracil (5-Fu) in human HCC cells, HepG2, Hep3B, and HepJ5. The present study indicated that FWGE exhibited potential to suppress HepG2, Hep3B, and HepJ5 cells, with the half maximal inhibitory concentrations (IC50) of FWGE were 0.494, 0.371 and 1.524 mg/mL, respectively. FWGE also induced Poly (Adenosine diphosphate ribose) polymerase (PARP) associated cell death in Hep3B cells. Moreover, the FWGE treatment further enhanced the cytotoxicity of cisplatin in all tested HCC cells, and cytotoxicity of 5-Fu in a synergistic manner in HepJ5 cells. Collectively, the results identified the anti-tumor efficacy of FWGE in HCC cells and suggested that FWGE can be used as a supplement to effectively improve the tumor suppression efficiency of cisplatin and 5-Fu in HCC cells.
肝细胞癌 (HCC) 是全球癌症相关死亡的最常见原因之一。由于早期诊断困难,大多数患者无法进行治愈性治疗。姑息性治疗,如化疗,往往与低反应率、强烈的不良反应和对患者的有限临床益处相关。具有抗肿瘤功效的发酵麦芽提取物 (FWGE) 等替代方法可能会改善 HCC 当前治疗的临床效果。本研究旨在阐明 FWGE 的抗肿瘤功效以及 FWGE 与化疗药物顺铂和 5-氟尿嘧啶 (5-Fu) 在人 HCC 细胞 HepG2、Hep3B 和 HepJ5 中的联合药物效应。本研究表明,FWGE 具有抑制 HepG2、Hep3B 和 HepJ5 细胞的潜力,FWGE 的半最大抑制浓度 (IC50) 分别为 0.494、0.371 和 1.524mg/mL。FWGE 还诱导 Hep3B 细胞中聚 (腺苷二磷酸核糖) 聚合酶 (PARP) 相关的细胞死亡。此外,FWGE 处理进一步增强了顺铂在所有测试的 HCC 细胞中的细胞毒性,并以协同方式增强了 5-Fu 在 HepJ5 细胞中的细胞毒性。总之,这些结果确定了 FWGE 在 HCC 细胞中的抗肿瘤功效,并表明 FWGE 可作为一种补充剂,有效提高 HCC 细胞中顺铂和 5-Fu 的肿瘤抑制效率。